FDA Determines Regulatory Review Period for Allergen Patch Test Patent Extension

Summary

The FDA has published a notice determining the regulatory review period for the Allergen Patch Test (Thin-layer Rapid Use Epicutaneous (T.R.U.E.) Test) patent extension application, submitted by the Commissioner of Patents and Trademarks, Department of Commerce, for a human biologic product patent extension.